首页> 外文期刊>Cytotherapy >Individual and synergistic cytokine effects controlling the expansion of cord blood CD34~+ cells and megakaryocyte progenitors in culture
【24h】

Individual and synergistic cytokine effects controlling the expansion of cord blood CD34~+ cells and megakaryocyte progenitors in culture

机译:单个和协同细胞因子作用控制培养中脐血CD34〜+细胞和巨核祖细胞的扩增

获取原文
获取原文并翻译 | 示例
           

摘要

Background aims. Expansion of hematopoietic progenitors ex vivo is currently investigated as a means of reducing cytopenia following stem cell transplantation. The principal objective of this study was to develop a new cytokine cocktail that would maximize the expansion of megakaryocyte (Mk) progenitors that could be used to reduce periods of thrombocytopenia. Methods. We measured the individual and synergistic effects of six cytokines [stem cell factor (SCF), FLT-3 ligand (FL), interleukin (IL)-3, IL-6, IL-9 and IL-11] commonly used to expand cord blood (CB) CD34~+ cells on the expansion of CB Mk progenitors and major myeloid populations by factorial design. Results. These results revealed an elaborate array of cytokine individual effects complemented by a large number of synergistic and antagonistic interaction effects. Notably, strong interactions with SCF were observed with most cytokines and its concentration level was the most influential factor for the expansion and differentiation kinetics of CB CD34~+ cells. A response surface methodology was then applied to optimize the concentrations of the selected cytokines. The newly developed cocktail composed of SCF, thrombopoietin (TPO) and FL increased the expansion of Mk progenitors and maintained efficient expansion of clonogenic progenitors and CD34+ cells. CB cells expanded with the new cocktail were shown to provide good short- and long-term human platelet recovery and lymphomyeloid reconstitution in NOD/SCID mice. Conclusions. Collectively, these results define a complex cytokine network that regulates the growth and differentiation of immature and committed hematopoietic cells in culture, and confirm that cytokine interactions have major influences on the fate of hematopoietic cells.
机译:背景目标。目前已经研究了离体造血祖细胞的扩增,作为减少干细胞移植后血细胞减少的一种手段。这项研究的主要目的是开发一种新的细胞因子混合物,该混合物将使巨核细胞(Mk)祖细胞的扩增最大化,从而可用于减少血小板减少的时期。方法。我们测量了通常用于扩增脐带的六种细胞因子[干细胞因子(SCF),FLT-3配体(FL),白介素(IL)-3,IL-6,IL-9和IL-11]的个体和协同作用。析因设计使血液(CB)CD34〜+细胞对CB Mk祖细胞和主要髓样群体的扩增产生作用。结果。这些结果揭示了一系列复杂的细胞因子个体效应,并辅以大量的协同和拮抗相互作用。值得注意的是,在大多数细胞因子中均观察到与SCF的强相互作用,其浓度水平是影响CB CD34〜+细胞扩增和分化动力学的最主要因素。然后应用响应表面方法优化所选细胞因子的浓度。新开发的由SCF,血小板生成素(TPO)和FL组成的混合物增加了Mk祖细胞的扩增,并保持了成克隆祖细胞和CD34 +细胞的有效扩增。研究表明,用这种新混合物扩增的CB细胞可在NOD / SCID小鼠中提供良好的短期和长期人血小板恢复以及淋巴细胞的重组。结论总而言之,这些结果定义了一个复杂的细胞因子网络,该网络调节培养物中未成熟和定型造血细胞的生长和分化,并证实细胞因子相互作用对造血细胞的命运有重要影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号